Buprenorphine HCL Injectable
Buprenorphine HCl Injectable is a veterinary opioid analgesic used to provide effective relief from moderate to severe pain in pets. It acts quickly and offers several hours of comfort, making it useful for post-surgical care or acute pain management. Administered by a veterinarian, it helps keep pets comfortable during recovery.
Giving your pet an injection might feel intimidating at first, but with practice, it becomes routine. Follow these steps for safe and stress-free injections.
Get Your Supplies Ready
- Medication vial or pre-filled syringe
- Alcohol swabs
- Sterile syringe & needle (if not pre-filled)
- Sharps container for safe needle disposal
Drawing Up the Dose (if needed)
- Clean the vial top with an alcohol swab
- Attach needle to syringe
- Pull in air equal to the dose
- Insert needle into vial, push air in
- Draw out the correct dose
- Tap out air bubbles
Pick the Injection Site
- Subcutaneous (under the skin): Loose skin between shoulder blades or side
- Intramuscular (into muscle): As directed by your vet
Prep the Area
- Pinch a fold of skin to form a “tent” (for subcutaneous). Wipe with alcohol if recommended.
Inject the Medication
- Hold the syringe like a pencil
- Insert the needle into the base of the skin tent at a 45° angle
- Push the plunger slowly to inject
After the Injection
- Remove the needle smoothly
- Place it immediately in the sharps container (don’t recap)
- Pat the area and give your pet praise or a treat
Safety Tips
- Never reuse needles
- Always dispose of used needles properly
- Ask your vet for help if unsure
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider buprenorphine hydrochloride in the context of acute pain management, particularly for perioperative care or following traumatic injury. It is frequently a point of discussion for feline patients because of its unique ability to be absorbed across the oral mucous membranes, providing a non-invasive administration route. By targeting specific receptors in the central nervous system, your veterinarian can manage the physiological signals associated with discomfort.
At a pharmacological level, buprenorphine acts as a partial mu-opioid receptor agonist and a kappa-opioid receptor antagonist. It possesses an extremely high affinity for the mu-receptor, which results in a long duration of action, even though it does not produce the same maximal effect as full agonists. Because it binds so tightly to these receptors, it can compete with and displace other medications from the same site. This high affinity also means the medication dissociates slowly from the receptor, contributing to its sustained influence on the patient’s comfort level. Your veterinarian will determine the clinical appropriateness of buprenorphine based on the severity of the anticipated discomfort and your pet’s overall health status.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of buprenorphine include sedation, localized digestive changes such as decreased appetite and behavioral shifts. In feline patients, veterinarians frequently observe mydriasis (dilated pupils) or localized euphoria, while canine patients may occasionally exhibit panting or mild respiratory depression. Owners should monitor for excessive lethargy or disorientation and contact their veterinarian promptly with any concerns.
This medication is typically used with extra caution or avoided in patients with known severe respiratory disease, head trauma or compromised hepatic function, as the liver is the primary site of metabolism for this prescription. Because buprenorphine binds so strongly to receptors, it may interfere with the effectiveness of other opioid medications if they are required simultaneously. Before starting a protocol, ensure your veterinarian has a complete history of all other medications your pet is receiving. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most commonly considered monitoring schedule to ensure the management approach remains suitable for your pet's individual recovery needs.
Yes. Buprenorphine hydrochloride is a potent prescription medication and a controlled substance, meaning it can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab complies with all state and federal regulations regarding the dispensing of controlled medications.
Yes. While buprenorphine is available as a commercial injectable, Mixlab can compound it into customized strengths and alternative dosage forms, such as flavored oral liquids for transmucosal absorption, to suit the specific needs of your pet. The decision to use a compounded preparation rests with the prescribing veterinarian based on the clinical context.
Veterinarians often recommend transmucosal administration for cats because buprenorphine is absorbed very efficiently through the lining of the mouth directly into the bloodstream. This method is often preferred because it avoids the "first-pass" metabolism by the liver that occurs when a medication is swallowed, allowing for more commonly considered management of discomfort.
Sedation is a commonly observed effect of buprenorphine and most other opioid medications. While a degree of relaxation is often a clinical objective during recovery, you should report any signs of profound lethargy or difficulty waking up to your veterinarian immediately to ensure the dose remains appropriate for your pet.
